Rosetta Genomics Ltd. buy melinda
Start price
07.04.17
/
50%
€2.40
Target price
17.05.17
€3.61
Performance (%)
-40.39%
End price
17.05.17
€1.43
Summary
This prediction ended on 17.05.17 with a price of €1.43. The BUY prediction by melinda for Rosetta Genomics Ltd. performed very badly with a performance of -40.39%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Rosetta Genomics Ltd. | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by melinda for this prediction
In the thread Rosetta Genomics Ltd. diskutieren
Gesundheit | Medical Laboratories & Forschung | Israel
hat $
(Vom Mitglied beendet)
Stopped prediction by melinda for Rosetta Genomics Ltd.
Rosetta Genomics Ltd.
Start price
Target price
Perf. (%)
€0.97
03.10.17
03.10.17
€1.35
27.12.17
27.12.17
-48.91%
27.12.17
27.12.17
Rosetta Genomics Ltd.
Start price
Target price
Perf. (%)
€1.08
03.10.17
03.10.17
€1.50
27.12.17
27.12.17
-48.91%
27.12.17
27.12.17
Rosetta Genomics Ltd.
Start price
Target price
Perf. (%)
€1.33
17.05.17
17.05.17
€1.80
25.05.17
25.05.17
38.52%
25.05.17
25.05.17